Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $885 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a price target of $885.
September 09, 2024 | 3:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly, maintaining a price target of $885. This suggests confidence in the company's future performance.
The reiteration of an Overweight rating and a high price target of $885 by a reputable analyst suggests a positive outlook for Eli Lilly's stock. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100